US Bancorp DE Has $7.76 Million Holdings in Humana Inc. $HUM

Key Points

• US Bancorp DE increased its holdings in Humana Inc. by 13.4% during the second quarter, bringing their total ownership to 31,745 shares valued at approximately $7.76 million.
• Humana's quarterly earnings report showed earnings per share of $6.27, which fell short of the consensus estimate, though revenue increased by 9.6% year-over-year.
• The company announced a quarterly dividend of $0.885 per share, with a yield of 1.3%, scheduled for payment on October 31st.

US Bancorp DE lifted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 13.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 31,745 shares of the insurance provider's stock after purchasing an additional 3,749 shares during the period. US Bancorp DE's holdings in Humana were worth $7,761,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the business. Maryland State Retirement & Pension System lifted its holdings in shares of Humana by 4.1% during the second quarter. Maryland State Retirement & Pension System now owns 5,867 shares of the insurance provider's stock worth $1,434,000 after purchasing an additional 231 shares during the period. Venturi Wealth Management LLC acquired a new position in shares of Humana during the second quarter worth $218,000. KLP Kapitalforvaltning AS lifted its holdings in shares of Humana by 6.5% during the second quarter. KLP Kapitalforvaltning AS now owns 44,370 shares of the insurance provider's stock worth $10,881,000 after purchasing an additional 2,700 shares during the period. Prime Capital Investment Advisors LLC lifted its holdings in shares of Humana by 10.6% during the second quarter. Prime Capital Investment Advisors LLC now owns 953 shares of the insurance provider's stock worth $233,000 after purchasing an additional 91 shares during the period. Finally, Sendero Wealth Management LLC lifted its holdings in shares of Humana by 28.2% during the second quarter. Sendero Wealth Management LLC now owns 4,440 shares of the insurance provider's stock worth $1,085,000 after purchasing an additional 978 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Price Performance

HUM stock opened at $280.24 on Monday. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The firm has a market cap of $33.71 billion, a price-to-earnings ratio of 21.51, a PEG ratio of 1.64 and a beta of 0.42. The company's fifty day simple moving average is $279.45 and its 200 day simple moving average is $258.04.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. During the same period last year, the firm posted $6.96 earnings per share. The company's revenue for the quarter was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. On average, analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana's payout ratio is 27.17%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on HUM shares. Barclays cut their price target on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating on the stock in a report on Friday, October 3rd. Guggenheim reiterated a "buy" rating on shares of Humana in a report on Friday, October 3rd. Wall Street Zen lowered shares of Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Morgan Stanley dropped their target price on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a report on Thursday, July 31st. Finally, Evercore ISI initiated coverage on shares of Humana in a report on Monday, September 22nd. They issued an "in-line" rating and a $295.00 target price on the stock. Eight investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $298.83.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.